Novavax, Inc.

Anushree Herwadkar

Gale Smith

Jing-Hui Tian

Jason Wong

Sarathi Boddapati

Yen-Huei Lin

Disclosed herein are multivalent nanoparticle vaccine compositions suitable for use in influenza vaccines. The nanoparticles include effective amounts of influenza glycoproteins that provide increased immune responses compared to a commercially available influenza vaccine composition. The present disclosure also provides vaccine formulation strategies that are cost effective and are convenient for clinical use. Methods of administering the nanoparticle vaccine compositions to a subject are also disclosed.

Growing community of inventors

Clarksburg, MD, United States of America

Anushree Herwadkar